20 times has been offered for biotech in the past as has lower...

20 times has been offered for biotech in the past as has lower figures.

It all depends on prospects going forward and their certainty.

Of course, Big Pharma will look at things if they see revenue going through the roof in the long term and offer a big discount on that long term at a much lower price in the short term.

Take overs do occur to shut down a threat as well to existing revenue.......

SI can't be forced to sell, but he can lose control in my view, but achieving that will drive the price very high.

We could see competing offers down the road.

Big Pharma is building big complexes for as yet unknown products.......

Why the secrecy one may ask.....

Maybe it is IMU that has to worry more?